The DOI matches its Crossref record; 48 of the 48 references it cites were found in a registry or an index.
TLR4 links innate immunity and fatty acid-induced insulin resistance
Open accessAbstract
TLR4 is the receptor for LPS and plays a critical role in innate immunity. Stimulation of TLR4 activates proinflammatory pathways and induces cytokine expression in a variety of cell types. Inflammatory pathways are activated in tissues of obese animals and humans and play an important role in obesity-associated insulin resistance. Here we show that nutritional fatty acids, whose circulating levels are often increased in obesity, activate TLR4 signaling in adipocytes and macrophages and that the capacity of fatty acids to induce inflammatory signaling in adipose cells or tissue and macrophages is blunted in the absence of TLR4. Moreover, mice lacking TLR4 are substantially protected from the ability of systemic lipid infusion to (a) suppress insulin signaling in muscle and (b) reduce insulin-mediated changes in systemic glucose metabolism. Finally, female C57BL/6 mice lacking TLR4 have increased obesity but are partially protected against high fat diet-induced insulin resistance, possibly due to reduced inflammatory gene expression in liver and fat. Taken together, these data suggest that TLR4 is a molecular link among nutrition, lipids, and inflammation and that the innate immune system participates in the regulation of energy balance and insulin resistance in response to changes in the nutritional environment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Shi et al. showed that FFA activates TLR4 signaling and that mice lacking TLR4 are partially protected against high fat diet-induced insulin resistance (306).”
From IL-6 in inflammation, autoimmunity and cancer (2021) · cites this paper as [306]
Experimental — accuracy not yet measuredIn the citing paper
“For instance, activation of TLR4 via LPS leads to the release of pro-inflammatory cytokines (e.g., TNF, interleukin [IL]-6), but similar effects are also observed if free fatty acids bind to TLR4.63”
From An integrated view of anti-inflammatory and antifibrotic targets for the treatment of NASH (2023) · cites this paper as [63]
In the citing paper
“A number of free fatty acid products released from necrotic adipocytes have been shown to cause pro-inflammatory activation of macrophages through TLR-2 and TLR-4 signaling pathways, suggesting a potential mechanism by which obesity-induced inflammation may occur [73,74].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [74]
In the citing paper
“A number of studies have shown that TLR-4 deficient mice are not protected from diet-induced obesity, but are protected from obesity-induced insulin resistance [74,76,77].”
From Macrophage polarization: an opportunity for improved outcomes in biomaterials and regenerative medicine (2012) · cites this paper as [74]
In the citing paper
“Probiotics intake may improve markers of insulin metabolism and lipid profiles by reducing cytokines and suppressing the nuclear factor kappa-light-chain-enhancer of activated B cells (NF-κB) pathway (Shi et al., 2006) and gut microbiota-short chain fatty acids (SCFA)-hormone axis (Yadav et al., 2013).”
From Effect of Probiotic Supplementation on Cognitive Function and Metabolic Status in Alzheimer's Disease: A Randomized, Double-Blind and Controlled Trial (2016) · cites this paper as Shi et al., 2006
In the citing paper
“Weight loss induced by gastric bypass reduced the circulating concentrations of visfatin (123) and TNF-a (124,125) .”
From Dietary factors and low-grade inflammation in relation to overweight and obesity (2011) · cites this paper as [125]
In the citing paper
“An important component of these fatty acid-induced activation events are the pattern recognition receptors TLR2 and TLR4 (105, 114-116).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [116]
In the citing paper
“In line with this, Tlr4-KO mice are protected against lipid-and obesity-induced insulin resistance (116, 117).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [116]
In the citing paper
“Clearly, ATMs exist in a lipid-rich environment and fatty acids can broadly activate the macrophage inflammatory program (105, 114-116).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [116]
In the citing paper
“Activation of inflammation is prevented in macrophages and adipocytes that are deficient in Tlr2, Tlr4, or Tlr2/Tlr4 (105, 114-116).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [116]
In the citing paper
“Dietary-derived saturated fatty acids [26] and erythrocyte content of saturated fatty acids (indicator of long-term consumption) [27], positively correlate with circulating measures of CRP and can contribute to inflammation by favoring TLR4 signaling in macrophages [67].”
From The menace of obesity to depression and anxiety prevalence (2022) · cites this paper as [67]
In the citing paper
“However, FFAs can also serve as ligands for the TLR4 complex (33), thereby activating the classical inflammatory response in the context of increased local extracellular lipid concentrations, which ultimately drives ATMΦ accumulation (34,35).”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [33]
In the citing paper
“Even though we do not consider AT as a conventional tissue suffering from lipotoxic side effects, either high rates of lipolysis or an influx of saturated FFAs into adipocytes do cause temporary inflammation within the tissue (33).”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [33]
In the citing paper
“TLR4, specifically, has been shown to mediate inflammatory responses to free fatty acids, which are elevated in obesity and are associated with insulin resistance38.”
From Sterile inflammation: sensing and reacting to damage (2010) · cites this paper as [38]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Obesity is associated with macrophage accumulation in adipose tissue
Weisberg, S. P., McCann, D., Desai, M., Rosenbaum, M., Leibel, R. L., & Ferrante, A. W. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319246 · Cited by 10,041
Xu, H., Barnes, G. T., Yang, Q., Tan, G., Yang, D., Chou, C. J., Sole, J., Nichols, A., Ross, J. S., Tartaglia, L. A., et al. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200319451 · Cited by 6,760
Yamauchi, T., Kamon, J., Waki, H., Terauchi, Y., Kubota, N., Hara, K., Mori, Y., Ide, T., Murakami, K., Tsuboyama-Kasaoka, N., et al. (2001) · Nature Medicine · doi:10.1038/90984 · Cited by 4,915
The hormone resistin links obesity to diabetes
Steppan, C. M., Bailey, S. T., Bhat, S., Brown, E. J., Banerjee, R. R., Wright, C. M., Patel, H. R., Ahima, R. S., & Lazar, M. A. (2001) · Nature · doi:10.1038/35053000 · Cited by 4,755
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Inflammation, stress, and diabetes
Wellen, K. E., & Hotamisligil, G. S. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25102 · Cited by 4,143
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
Hoshino, K., Takeuchi, O., Kawai, T., Sanjo, H., Ogawa, T., Takeda, Y., Takeda, K., & Akira, S. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.162.7.3749 · Cited by 3,374
A central role for JNK in obesity and insulin resistance
Hirosumi, J., Tuncman, G., Chang, L., Görgün, C. Z., Uysal, K. T., Maeda, K., Karin, M., & Hotamisligil, G. S. (2002) · Nature · doi:10.1038/nature01137 · Cited by 3,359
Obesity and insulin resistance
Kahn, B. B., & Flier, J. S. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10842 · Cited by 3,345
Self-citation
Flagged first, then by citations
Research works printed but not linked: 1
- 10.1172/JCI200525102 · DOI · Paper page
Cited by
Sorted by citations
Items 601–700 of 1,030
Muscle sphingolipids during rest and exercise: a C18:0 signature for insulin resistance in humans
Bergman, B. C., Brozinick, J. T., Strauss, A., Bacon, S., Kerege, A., Bui, H. H., Sanders, P., Siddall, P., Wei, T., Thomas, M. K., et al. (2016) · Diabetologia · doi:10.1007/s00125-015-3850-y · Cited by 148
Microbiota, Inflammation and Obesity
Sanz, Y., & Moya-Pérez, Á. (2014) · Advances in experimental medicine and biology · doi:10.1007/978-1-4939-0897-4_14 · Cited by 151
Metabolic Regulation of Adipose Tissue Macrophage Function in Obesity and Diabetes
Appari, M., Channon, K. M., & McNeill, E. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7060 · Cited by 154
Lipid Mediators of Insulin Resistance
Holland, W. L., Knotts, T. A., Chavez, J. A., Wang, L.-P., Hoehn, K. L., & Summers, S. A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00327.x · Cited by 149
Role of Lipotoxicity in Endothelial Dysfunction
Kim, J., Montagnani, M., Chandrasekran, S., & Quon, M. J. (2012) · Heart Failure Clinics · doi:10.1016/j.hfc.2012.06.012 · Cited by 153
Ли, Б., Leung, J. C. K., Chan, L. Y. Y., Yiu, W. H., & Tang, S. C. W. (2019) · Progress in Lipid Research · doi:10.1016/j.plipres.2019.101020 · Cited by 149
Macrophages, Meta-Inflammation, and Immuno-Metabolism
Shapiro, H., Lutaty, A., & Ariel, A. (2011) · The Scientific World JOURNAL · doi:10.1100/2011/397971 · Cited by 153
Toll-like receptors, inflammation, metabolism and obesity
Fresno, M., Álvarez, R., & Cuesta, N. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.562514 · Cited by 150
Du, P., Han, H., Han, H., Zhen, J., Shang, J., Wang, X., Li, X., Shi, W., Tang, W., Bao, C., et al. (2013) · Kidney International · doi:10.1038/ki.2013.113 · Cited by 145
Neuroinflammatory basis of metabolic syndrome
Purkayastha, S., & Cai, D. (2013) · Molecular Metabolism · doi:10.1016/j.molmet.2013.09.005 · Cited by 150
Johannsen, D. L., Tchoukalova, Y. D., Tam, C. S., Covington, J. D., Xie, W., Schwarz, J., Bajpeyi, S., & Ravussin, É. (2014) · Diabetes Care · doi:10.2337/dc14-0761 · Cited by 151
Hypothalamic dysfunction in obesity
Williams, L. M. (2012) · Proceedings of The Nutrition Society · doi:10.1017/s002966511200078x · Cited by 148
Epidemiological and Experimental Links between Air Pollution and Type 2 Diabetes
Liu, C., Ying, Z., Harkema, J. R., Sun, Q., & Rajagopalan, S. (2012) · Toxicologic Pathology · doi:10.1177/0192623312464531 · Cited by 149
B Lymphocytes in obesity-related adipose tissue inflammation and insulin resistance
Winer, D. A., Winer, S., Chng, M. H. Y., Shen, L., & Engleman, E. G. (2013) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-013-1486-y · Cited by 150
Modulation of obesity-induced inflammation by dietary fats: mechanisms and clinical evidence
Teng, K., Chang, C.-Y., Chang, L. F., & Nesaretnam, K. (2014) · Nutrition Journal · doi:10.1186/1475-2891-13-12 · Cited by 151
MicroRNA-223 is a crucial mediator of PPARγ-regulated alternative macrophage activation
Ying, W., Tseng, A., Chang, R. C.-A., Morin, A., Brehm, T., Triff, K., Nair, V., Zhuang, G., Song, H., Kanameni, S., et al. (2015) · Journal of Clinical Investigation · doi:10.1172/jci81656 · Cited by 144
Mechanisms of Macrophage Polarization in Insulin Signaling and Sensitivity
Orliaguet, L., Dalmas, É., Drareni, K., Venteclef, N., & Alzaïd, F. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00062 · Cited by 151
Mechanisms of NLRP3 priming in inflammaging and age related diseases
Gritsenko, A., Green, J., Brough, D., & López‐Castejón, G. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.08.003 · Cited by 146
Adipose tissue macrophage in obesity-associated metabolic diseases
Yao, J., Wu, D., & Qiu, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.977485 · Cited by 151
Autoimmunity in atherosclerosis: a protective response losing control?
Nilsson, J. Å., & Hansson, G. K. (2008) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2008.01945.x · Cited by 142
Innate immune activation in obesity
Lumeng, C. N.-K. (2012) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2012.10.002 · Cited by 147
The role of the complement system in metabolic organs and metabolic diseases
Phieler, J., García-Martín, R., Lambris, J. D., & Chavakis, T. (2013) · Seminars in Immunology · doi:10.1016/j.smim.2013.04.003 · Cited by 142
Lee, J. Y., Zhao, L., & Hwang, D. H. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00259.x · Cited by 147
Huang, Z. P., & Xu, A. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.608680 · Cited by 153
The Macrophage at the Crossroads of Insulin Resistance and Atherosclerosis
Liang, C.-P., Han, S., Senokuchi, T., & Tall, A. R. (2007) · Circulation Research · doi:10.1161/circresaha.107.152165 · Cited by 143
Caricilli, A. M., Nascimento, P. H., Pauli, J. R., Tsukumo, D. M. L., Velloso, L. A., Carvalheira, J. B. C., & Saad, M. J. A. (2008) · Journal of Endocrinology · doi:10.1677/joe-08-0354 · Cited by 143
Signaling pathways involved in LPS induced TNFalpha production in human adipocytes
Hoareau, L., Bencharif, K., Rondeau, P., Murumalla, R. K., Ravanan, P., Tallet, F., Delarue, P., Césari, M., Roche, R., & Festy, F. (2010) · Journal of Inflammation · doi:10.1186/1476-9255-7-1 · Cited by 143
Melo, H. M., Seixas da Silva, G. D. S., Sant’Ana, M. R., Teixeira, C. V. L., Clarke, J. R., Miya Coreixas, V. S., de Melo, B. C., Fortuna, J. T. S., Forny-Germano, L., Ledo, J. H., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.01.072 · Cited by 140
Nuclear Receptors and Inflammation Control: Molecular Mechanisms and Pathophysiological Relevance
Huang, W. J. M., & Glass, C. K. (2010) · Arteriosclerosis Thrombosis and Vascular Biology · doi:10.1161/atvbaha.109.191189 · Cited by 142
Dragano, N. R. V., Solon, C., Ramalho, A. F. S., de Moura, R. F., Razolli, D. S., Christiansen, E., Azevedo, C., Ulven, T., & Velloso, L. A. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0869-7 · Cited by 146
Necela, B. M., Su, W., & Thompson, E. A. (2008) · Immunology · doi:10.1111/j.1365-2567.2008.02849.x · Cited by 140
Pathogenesis of Type 2 Diabetes Mellitus
Al-Saraj, F. (2015) · InTech eBooks · doi:10.5772/59183 · Cited by 141
Activating Transcription Factor 4 Links Metabolic Stress to Interleukin-6 Expression in Macrophages
Iwasaki, Y., Suganami, T., Hachiya, R., Shirakawa, I., Kim-Saijo, M., Tanaka, M., Hamaguchi, M., Takai-Igarashi, T., Nakai, M., Miyamoto, Y., et al. (2013) · Diabetes · doi:10.2337/db13-0757 · Cited by 127
Lopes, H. F., Corrêa‐Giannella, M. L., Consolim‐Colombo, F. M., & Egan, B. M. (2016) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-016-0156-2 · Cited by 147
Free Fatty Acids and Skeletal Muscle Insulin Resistance
Rachek, L. I. (2014) · Progress in molecular biology and translational science · doi:10.1016/b978-0-12-800101-1.00008-9 · Cited by 141
Meli, R., Mattace Raso, G., & Calignano, A. (2014) · Frontiers in Immunology · doi:10.3389/fimmu.2014.00177 · Cited by 137
Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health
Ha, C. W. (2014) · World Journal of Gastroenterology · doi:10.3748/wjg.v20.i44.16498 · Cited by 137
Winer, S., & Winer, D. A. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2011.110 · Cited by 141
Oncogenic role and therapeutic target of leptin signaling in breast cancer and cancer stem cells
Guo, S., Liu, M., Wang, G., Torroella‐Kouri, M., & Gonzalez-Perez, R. R. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.01.002 · Cited by 139
Getting the message across: mechanisms of physiological cross talk by adipose tissue
Lee, D.-E., Kehlenbrink, S., Lee, H., Hawkins, M. A., & Yudkin, J. S. (2009) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00015.2009 · Cited by 140
Microbiota and epigenetic regulation of inflammatory mediators in type 2 diabetes and obesity
Remely, M., Aumueller, E., Jahn, D., Hippe, B., Brath, H., & Haslberger, A. G. (2014) · Beneficial Microbes · doi:10.3920/bm2013.006 · Cited by 141
The biochemical alterations underlying post-burn hypermetabolism
Auger, C., Samadi, O., & Jeschke, M. G. (2017) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2017.02.019 · Cited by 143
Wood, L. G., Li, Q., Scott, H. A., Rutting, S., Berthon, B. S., Gibson, P. G., Hansbro, P. M., Williams, E. J., Horvat, J. C., Simpson, J. L., et al. (2018) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2018.04.037 · Cited by 137
Diet-Derived Fatty Acids, Brain Inflammation, and Mental Health
Melo, H. M., Santos, L. E., & Ferreira, S. T. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00265 · Cited by 136
Su, B., Liu, H., Li, J., Sunli, Y., Liu, B., Liu, D., Zhang, P., & Meng, X. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12232 · Cited by 136
Oliver, E., McGillicuddy, F. C., Phillips, C. M., Toomey, S., & Roche, H. M. (2010) · Proceedings of The Nutrition Society · doi:10.1017/s0029665110000042 · Cited by 141
Martínez-Colón, G. J., Ratnasiri, K., Chen, R., Jiang, S., ZANLEY, E. J., Rustagi, A., Verma, R., Chen, H. M., Andrews, J. R., Mertz, K. D., et al. (2022) · Science Translational Medicine · doi:10.1126/scitranslmed.abm9151 · Cited by 140
Sphingolipids in High Fat Diet and Obesity‐Related Diseases
Choi, S., & Snider, A. J. (2015) · Mediators of Inflammation · doi:10.1155/2015/520618 · Cited by 136
Role of the NLRP3 Inflammasome in Preeclampsia
Shirasuna, K., Karasawa, T., & Takahashi, M. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00080 · Cited by 139
Sampey, B. P., Freemerman, A. J., Zhang, J., Kuan, P. F., Galanko, J. A., O’Connell, T. M., Ilkayeva, O., Muehlbauer, M. J., Stevens, R. D., Newgard, C. B., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0038812 · Cited by 135
Inflammatory Concepts of Obesity
Rocha, V. Z., & Folco, E. J. E. (2011) · International Journal of Inflammation · doi:10.4061/2011/529061 · Cited by 140
Oliveira, A. G., Carvalho, B. M., Tobar, N., Ropelle, E. R., Pauli, J. R., Bagarolli, R. A., Guadagnini, D., Carvalheira, J. B. C., & Saad, M. J. A. (2011) · Diabetes · doi:10.2337/db09-1907 · Cited by 136
RetractedJafarnejad, S., Saremi, S., Jafarnejad, F., & Arab, A. (2016) · Journal of Nutrition and Metabolism · doi:10.1155/2016/5190846 · Cited by 135
Metabolic Syndrome and Skin Diseases
Hu, Y., Zhu, Y. X., Lian, N., Chen, M., Bartke, A., & Yuan, R. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00788 · Cited by 137
Phytosterols: Nutritional Health Players in the Management of Obesity and Its Related Disorders
Vezza, T., Canet, F., Marañón, A., Bañuls, C., Rocha, M., & Víctor, V. M. (2020) · Antioxidants · doi:10.3390/antiox9121266 · Cited by 136
Poulsen, M. M., Fjeldborg, K., Ørnstrup, M. J., Kjær, T. N., Nøhr, M. K., & Pedersen, S. B. (2015) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2014.12.024 · Cited by 138
Metabolic Stress Signaling Mediated by Mixed-Lineage Kinases
Jaeschke, A., & Davis, R. J. (2007) · Molecular Cell · doi:10.1016/j.molcel.2007.07.008 · Cited by 137
Non-alcoholic fatty liver disease and its treatment with n-3 polyunsaturated fatty acids
de Castro, G. S., & Calder, P. C. (2017) · Clinical Nutrition · doi:10.1016/j.clnu.2017.01.006 · Cited by 137
Diabetes and Sepsis: Risk, Recurrence, and Ruination
Frydrych, L. M., Fattahi, F., He, K., Ward, P. A., & Delano, M. J. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00271 · Cited by 141
Inflammatory Mechanisms of Diabetes and Its Vascular Complications
Nedosugova, L. V., Markina, Y. V., Бочкарева, Л. А., Кузина, И. А., Petunina, N. A., Yudina, I. Y., & Kirichenko, T. V. (2022) · Biomedicines · doi:10.3390/biomedicines10051168 · Cited by 135
Kong, L. C., Holmes, B. A., Cotillard, A., Habi-Rachedi, F., Brazeilles, R., Gougis, S., Gausserès, N., Cani, P. D., Fellahi, S., Bastard, J.-P., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0109434 · Cited by 132
Role of macrophage tissue infiltration in obesity and insulin resistance
Bourlier, V., & Bouloumié, A. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2009.05.001 · Cited by 141
Chatterjee, P., Seal, S., Mukherjee, S., Kundu, R., Mukherjee, S., Ray, S., Mukhopadhyay, S., Majumdar, S. S., & Bhattacharya, S. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.c113.495473 · Cited by 132
Bolton, J. L., Auten, R. L., & Bilbo, S. D. (2013) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2013.10.029 · Cited by 136
Meshkani, R., & Vakili, S. (2016) · Clinica Chimica Acta · doi:10.1016/j.cca.2016.08.015 · Cited by 136
Interferon Regulatory Factors Are Transcriptional Regulators of Adipogenesis
Eguchi, J., Yan, Q.-W., Schones, D. E., Kamal, M., Hsu, C.-H., Zhang, M. Q., Crawford, G. E., & Rosen, E. D. (2008) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.002 · Cited by 132
The TLR4 antagonist CRX-526 protects against advanced diabetic nephropathy
Lin, M. Y., Yiu, W. H., Li, R. X., Wu, H., Wong, D. W. L., Chan, L. Y. Y., Leung, J. C. K., Lai, K. N., & Tang, S. C. W. (2013) · Kidney International · doi:10.1038/ki.2013.11 · Cited by 131
Voon, P. T., Ng, T. K. W., Lee, V. K. M., & Nesaretnam, K. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.111.020107 · Cited by 131
Benomar, Y., & Taouis, M. (2019) · Frontiers in Endocrinology · doi:10.3389/fendo.2019.00140 · Cited by 131
Obesity and the gastrointestinal microbiota: a review of associations and mechanisms
Graham, C., Mullen, A., & Whelan, K. (2015) · Nutrition Reviews · doi:10.1093/nutrit/nuv004 · Cited by 132
Insulin resistance and steatosis in humans
Capeau, J. (2008) · Diabetes & Metabolism · doi:10.1016/s1262-3636(08)74600-7 · Cited by 130
Rosales‐Corral, S., Tan, D., Manchester, L. C., & Reiter, R. J. (2015) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2015/985845 · Cited by 134
Protectin DX alleviates insulin resistance by activating a myokine-liver glucoregulatory axis
White, P. J., St‐Pierre, P., Charbonneau, A., Mitchell, P. L., St-Amand, E., Marcotte, B., & Marette, A. (2014) · Nature Medicine · doi:10.1038/nm.3549 · Cited by 136
Adiponectin as a potential biomarker of vascular disease
Mohammadi, S., Arefhosseini, S. R., Ebrahimi‐Mameghani, M., Fallah, P., & Bazi, Z. (2015) · Vascular Health and Risk Management · doi:10.2147/vhrm.s48753 · Cited by 129
A Novel Function of Adipocytes in Lipid Antigen Presentation to iNKT Cells
Huh, J. Y., Kim, J. I., Park, Y. J., Hwang, I., Lee, Y. S., Sohn, J. H., Lee, S. K., Alfadda, A. A., Kim, S. S., Choi, S. H., et al. (2012) · Molecular and Cellular Biology · doi:10.1128/mcb.00552-12 · Cited by 137
Eguchi, J., Kong, X., Tenta, M., Wang, X., Kang, S., & Rosen, E. D. (2013) · Diabetes · doi:10.2337/db12-1327 · Cited by 134
Profiling of the Three Circulating Monocyte Subpopulations in Human Obesity
Devêvre, E., Renovato‐Martins, M., Clément, K., Sautès‐Fridman, C., Cremer, I., & Poitou, C. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1402655 · Cited by 138
Sun, X., Hao, H., Han, Q., Song, X., Liu, J., Dong, L., Han, W., & Mu, Y. (2017) · Stem Cell Research & Therapy · doi:10.1186/s13287-017-0668-1 · Cited by 129
Alcoholic liver disease: A current molecular and clinical perspective
Ohashi, K., Pimienta, M., & Seki, E. (2018) · Liver Research · doi:10.1016/j.livres.2018.11.002 · Cited by 133
Wei, F., Wang, D., Wei, J., Tang, N., Tang, L. M., Xiong, F., Guo, C. J., Zhou, M., Li, X., Li, G., et al. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-020-03581-0 · Cited by 128
Adiponectin: A Promising Target for the Treatment of Diabetes and Its Complications
Begum, M., Choubey, M., Tirumalasetty, M. B., Arbee, S., Mohib, M. M., Wahiduzzaman, M., Mamun, M. A., Uddin, M. B., & Mohiuddin, M. S. (2023) · Life · doi:10.3390/life13112213 · Cited by 138
Inflammation is associated with a decrease of lipogenic factors in omental fat in women
Poulain‐Godefroy, O., Lecœur, C., Pattou, F. N., Frühbeck, G., & Froguel, P. (2008) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00926.2007 · Cited by 128
Amyot, J., Semache, M., Ferdaoussi, M., Fontès, G., & Poitout, V. (2012) · PLoS ONE · doi:10.1371/journal.pone.0036200 · Cited by 130
Embracing the gut microbiota: the new frontier for inflammatory and infectious diseases
van den Elsen, L. W. J., Poyntz, H., Weyrich, L. S., Young, W., & Forbes‐Blom, E. (2017) · Clinical & Translational Immunology · doi:10.1038/cti.2016.91 · Cited by 131
Ogawa, Y., Imajo, K., Honda, Y., Kessoku, T., Tomeno, W., Kato, S., Fujita, K., Yoneda, M., Saito, S., Saigusa, Y., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-29735-6 · Cited by 127
Complement activation in obesity, insulin resistance, and type 2 diabetes mellitus
Shim, K., Begum, R., Yang, C. F., & Wang, H. (2019) · World Journal of Diabetes · doi:10.4239/wjd.v11.i1.1 · Cited by 128
It's the fiber, not the fat: significant effects of dietary challenge on the gut microbiome
Morrison, K. E., Jašarević, E., Howard, C. D., & Bale, T. L. (2020) · Microbiome · doi:10.1186/s40168-020-0791-6 · Cited by 141
Contribution of specific ceramides to obesity-associated metabolic diseases
Hammerschmidt, P., & Brüning, J. C. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04401-3 · Cited by 133
Lanthier, N., Molendi‐Coste, O., Cani, P. D., van Rooijen, N., Horsmans, Y., & Leclercq, I. A. (2011) · The FASEB Journal · doi:10.1096/fj.11-189472 · Cited by 138
Wang, X., Yang, Z., Xue, B., & Shi, H. (2011) · Endocrinology · doi:10.1210/en.2010-0855 · Cited by 126
Self-citationToll-like receptors and diabetes: a therapeutic perspective
Dasu, M. R. K., Ramírez, S. M., & Isseroff, R. R. (2011) · Clinical Science · doi:10.1042/cs20110357 · Cited by 123
Gosejacob, D., Jäger, P. S., Dorp, K. V., Frejno, M., Carstensen, A., Köhnke, M., Degen, J., Dörmann, P., & Hoch, M. (2016) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.691212 · Cited by 129
Microbiome and diabetes: Where are we now?
Vallianou, N. G., Stratigou, T., & Tsagarakis, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.10.008 · Cited by 126
Festuccia, W. T., Pouliot, P., Bakan, I., Sabatini, D. M., & Laplante, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0095432 · Cited by 103
Palmitic acid is a toll-like receptor 4 ligand that induces human dendritic cell secretion of IL-1β
Nicholas, D., Zhang, K., Hung, C., Glasgow, S., Aruni, W., Unternaehrer, J., Payne, K. J., Langridge, W. H. R., & León, M. A. D. (2017) · PLoS ONE · doi:10.1371/journal.pone.0176793 · Cited by 132
Pathophysiology of type 2 diabetes and the impact of altered metabolic interorgan crosstalk
Sanches, J. M., Zhao, L. N., Salehi, A. A., Wollheim, C. B., & Kaldis, P. (2021) · FEBS Journal · doi:10.1111/febs.16306 · Cited by 136
Sex-based differences in insulin resistance
Gado, M., Tsaousidou, E., Bornstein, S. R., & Perakakis, N. (2024) · Journal of Endocrinology · doi:10.1530/joe-23-0245 · Cited by 126
Kim, S.-J., Choi, Y., Choi, Y., & Park, T. (2011) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2010.10.012 · Cited by 133
Metagenome and metabolism: the tissue microbiota hypothesis
Burcelin, R., Sérino, M., Chabo, C., Garidou, L., Pomié, C., Courtney, M., Amar, J., & Bouloumié, A. (2013) · Diabetes Obesity and Metabolism · doi:10.1111/dom.12157 · Cited by 130
Proatherogenic Conditions Promote Autoimmune T Helper 17 Cell Responses In Vivo
Lim, H., Kim, Y. U., Sun, H., Lee, J. H., Reynolds, J. M., Hanabuchi, S., Wu, H., Teng, B.-B., & Chung, Y. (2014) · Immunity · doi:10.1016/j.immuni.2013.11.021 · Cited by 126
Metadata
- Authors
- Shi, H., Kokoeva, M. V., Inouye, K., Tzameli, I., Yin, H., & Flier, J. S.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Corresponding author
- Flier, Jeffrey S.
- Venue
- Journal of Clinical Investigation
- Published
- 2006-11-01
- Volume
- 116
- Issue
- 11
- Pages
- 3015-3025
- ISSN
- 0021-9738 (ISSN-L)
- PMC
- PMC1616196
- OpenAlex
- W2156280702
- Cited by
- 3,690
- References
- 47
- Citations by year
- 2026: 126 · 2025: 131 · 2024: 135 · 2023: 140 · 2022: 167 · 2021: 176 · 2020: 209 · 2019: 180 · 2018: 206 · 2017: 243 · 2016: 220 · 2015: 259 · 2014: 222 · 2013: 274 · 2012: 252
- FWCI
- 86.79
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Journal of Clinical Investigation (publishedVersion)
- Europe PMC (PubMed Central) (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (DK-R37-28082, R37DK028082)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Keywords
- TLR4, lipopolysaccharide receptor, innate immunity, obesity, adipocytes, macrophages, inflammation, insulin signaling, glucose metabolism, high-fat diet, energy balance, TLR4-deficient mice
- MeSH terms
- Adipose Tissue, Animals, Cell Line, Fats, Fatty Acids, Female, Glucose, Humans, Immunity, Innate, Insulin Resistance, Macrophages, Muscles, Signal Transduction, Cytokines, NF-kappa B, Adipocytes, Genes, Reporter, Mice, Knockout, Toll-Like Receptor 4, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
